SULFONAMIDE, INHIBITORI AI ASPARTIL PROTEAZEI HIV, COMPOZIŢII FARMACEUTICE CARE ÎI CONŢIN ŞI METODĂ DE TRATAMENT
Price not visible for this package
Interest:
Assignment
Publication info:
No.: RO118747
Date: 30.10.2003
Inventor(s):
TUNG ROGER D [US]
MURCKO MARK A [US]
BHIDETTI GOVINDA RAO [US]
Applicant(s):
VERTEX PHARMA [US]
Classification:
International patent classification (IPC):
A61K31/16; A61K31/165; A61K31/17; A61K31/18; A61K31/255; A61K31/27; A61K31/325; A61K31/34; A61K31/341; A61K31/343; A61K31/35; A61K31/40; A61K31/4015; A61K31/403; A61K31/404; A61K31/41; A61K31/415; A61K31/42; A61K31/421; A61K31/4245; A61K31/425; A61K31/426; A61K31/44; A61K31/4402; A61K31/4418; A61K31/4433; A61K31/445; A61K31/47; A61K31/495; A61K31/496; A61K31/505; A61K31/535; A61K31/5375; A61K31/5377; A61K31/63; A61K38/55; A61P31/12; A61P31/18; C07C307/02; C07C307/06; C07C311/13; C07C311/18; C07C311/29; C07C311/39; C07C311/41; C07C311/46; C07D207/12; C07D207/26; C07D207/27; C07D207/28; C07D209/08; C07D209/10; C07D213/30; C07D215/48; C07D231/14; C07D239/22; C07D239/54; C07D263/24; C07D271/08; C07D277/20; C07D277/36; C07D295/12; C07D305/12; C07D307/12; C07D307/14; C07D307/20; C07D307/52; C07D307/64; C07D307/79; C07D403/12; C07D405/12; C07D409/12; C07D409/14; C07D413/12; C07D413/14; C07D417/12; C07D419/14; C07G99/00; C07K5/078; G01N33/53; G01N33/569; A61K38/00; C07D311/42
Cooperative patent classification (CPC):
A61P31/12 (EP); A61P31/18 (EP); C07C307/06 (EP, US); C07C311/13 (EP, US); C07C311/18 (EP, US); C07C311/29 (EP, US); C07C311/39 (EP, US); C07C311/46 (EP, US); C07D207/26 (EP, US); C07D209/08 (EP, US); C07D213/30 (EP, US); C07D213/78 (EP, US); C07D215/38 (EP, US); C07D215/48 (EP, US); C07D231/14 (EP, US); C07D239/22 (EP, US); C07D263/24 (EP, US); C07D271/08 (EP, US); C07D277/36 (EP, US); C07D307/12 (EP, US); C07D307/20 (EP, US); C07D403/12 (EP, US); C07D405/12 (EP, US); C07D409/12 (EP, US); C07D409/14 (EP, US); C07D413/12 (EP, US); C07D413/14 (EP, US); C07D417/12 (EP, US); C07K5/06139 (EP, US); A61K38/00 (EP, US); C07C2601/02 (EP, US); C07C2601/08 (EP, US); C07C2601/14 (EP, US)
Application info:
No.: RO19950000479
Date:
07.09.1993
Priority number(s):
US19920941982
08.09.1992
; WO1993US08458
07.09.1993
Related patents:
AP390; ATE178598; ATE241602; AU4852093; AU691160; BG62488; BG99540; BR1100824; CA2143208; CN1061339; CN1087347; CO4870779; CY2164; CZ289475; CZ58795; DE10199024; DE69324369; DE69333012; DK0659181; DK0885887; EP0659181; EP0885887; ES2131589; ES2200243; FI120685; FI951059; GEP20012579; GR3030719; HK1012631; HK1023561; HU228198; HUT71892; IL106927; IS2334; IS4068; JP3012002; JPH08501299; KR100262056; LT3302; LTIP917; LU90736; MXPA03010538; MY142901; NL300039; NO2001012; NO303444; NO950876; NZ256238; NZ314376; PH31251; PL185635; PL307858; PT885887; RU2135496; RU95109928; SG43862; SK281360; SK29395; TW254927; UA44694; US2003069222; US2006189810; US2008293727; US2010210603; US5585397; US5856353; US6372778; US7608632; WO9405639
Description:
Prezenta invenţie se referă la sulfonamide, inhibitori ai aspartil proteazei HIV, la compoziţiile farmaceutice care îi conţin şi la metoda de tratament. Sulfonamidele conform invenţiei sunt utilizate ca agenţi antivirali faţă de HIV-1 şi HIV-2, fiind folositori în tratamentul infecţiei HIV la un mamifer. ŕ
